Altamira Therapeutics Ltd. Current Financial Liabilities At Amortised Cost
Altamira Therapeutics Ltd. (CYTOF) had Current Financial Liabilities At Amortised Cost of $1.42 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:CurrentFinancialLiabilitiesAtAmortisedCost · last filed 2025-04-30
- 2023-12-31: Current Financial Liabilities At Amortised Cost 890.28K CHF.
- 2022-12-31: Current Financial Liabilities At Amortised Cost 13.50M CHF.
CHF
| Period end | Current Financial Liabilities At Amortised Cost |
|---|---|
| 2023-12-31 | 890.28K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 13.50M CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Current Financial Liabilities At Amortised Cost |
|---|---|
| 2024-12-31 | $1.42M 20-F · filed 2025-04-30 |
| 2023-12-31 | $1.06M 20-F · filed 2025-04-30 |